« Back to Record
Citation APA

Beex, L., Rose, C., Mouridsen, H., Jassem, J., Nooij, M., Estape, J., Paridaens, R., Piccart-Gebhart, M., Gorlia, T., Lardenoije, S., & Baila, L. (2006). Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863). European journal of cancer, 42(18), 3178-3185. doi:10.1016/j.ejca.2006.08.020


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/55431

Beex, L., Rose, C., Mouridsen, H., Jassem, J., Nooij, M., Estape, J., Paridaens, R., Piccart-Gebhart, M., Gorlia, T., Lardenoije, S., & Baila, L. (2006). Continuous versus intermittent tamoxifen versus intermittent/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863). European journal of cancer, 42(18), 3178-3185. doi:10.1016/j.ejca.2006.08.020